1.
Pigment Cell Melanoma Res
; 29(1): 101-3, 2016 Jan.
Article
in English
| MEDLINE
| ID: mdl-26176864
Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Bevacizumab/therapeutic use , Erlotinib Hydrochloride/therapeutic use , Melanoma/drug therapy , Melanoma/pathology , Antineoplastic Combined Chemotherapy Protocols/adverse effects , Bevacizumab/adverse effects , Disease-Free Survival , Erlotinib Hydrochloride/adverse effects , Humans , Neoplasm Metastasis , Treatment Outcome
2.
JAMA Oncol
; 1(8): 1167-8, 2015 Nov.
Article
in English
| MEDLINE
| ID: mdl-26225893